In addition, in untreated patients (v1) with stage III NSCLC, the differential circulating levels (Figure S1b) of HMGB1, ANXA1, CALR, and CXCL10 were not associated with PFS (Figure 3). This evidence concerns the gene CALR and non-small cell lung carcinoma.